drugset / Trial / NCT02868151

Effect of Oral Vitamin C in Assessing the Severity of Oral Mucositis in Chemoradiation of Head and Neck Cancers

NCT02868151

RandomizedParallel-groupSingle-blindSupportive care

Summary

The surrounding controversies both advocating and simultaneously opposing the use of vitamin C, mostly extrapolating animal models to human models, it has not been used individually to assess the severity of oral mucositis during chemoradiotherapy. The present study is undertaken to evaluate the effect of vitamin C oral supplements in assessing the severity of oral mucositis during chemoradiotherapy for oral cancer.

Timeline

Start
2016-08
Primary completion
2017-12
Completion
2018-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin C Other / unclassified 1 g Oral
Subject Zinc Sulfate Unknown 50 mg Oral

Indications